Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association*, Harmon Eyre, MD, Richard Kahn, PhD, Rose Marie Robertson, MD, FAHA, and the ACS/ADA/AHA Collaborative Writing Committee, Nathaniel G. Clark, MD, MS, RD, Colleen Doyle, MS, RD, Ted Gansler, MD, Thomas Glynn, PhD, Yuling Hong, MD, PhD, FAHA, Robert A. Smith, PhD, Kathryn Taubert, PhD, FAHA and Michael J. Thun, MD Dr. Eyre is Chief Medical Officer, American Cancer Society, Atlanta, GA. Dr. Kahn is Chief Scientific and Medical Officer, American Diabetes Association, Alexandria, VA. Dr. Robertson is Chief Science Officer, American Heart Association, Dallas, TX. Nathaniel G. Clark, MD, MS, RD, National Vice-President for Clinical Affairs, American Diabetes Association; Colleen Doyle, MS, RD, Director, Nutrition and Physical Activity, American Cancer Society; Ted Gansler, MD, Director of Medical Content, American Cancer Society; Thomas Glynn, PhD, Senior Director, International Tobacco Control, American Cancer Society; Yuling Hong, MD, PhD, FAHA, Director of Biostatistics and Epidemiology, American Heart Association; Robert A. Smith, PhD, Director of Cancer Screening, American Cancer Society; Kathryn Taubert, PhD, FAHA, Vice-President of Science and Medicine, American Heart Association; Michael J. Thun, MD, Vice President, Epidemiology and Surveillance, American Cancer Society. Collectively, cardiovascular disease (including stroke), cancer, and diabetes account for approximately two-thirds of all deaths in the United States and about $700 billion in direct and indirect economic costs each year. Current approaches to health promotion and prevention of cardiovascular disease, cancer, and diabetes do not approach the potential of the existing state of knowledge. A concerted effort to increase application of public health and clinical interventions of known efficacy to reduce prevalence of tobacco use, poor diet, and insufficient physical activity—the major risk factors for these diseases—and to increase utilization of screening tests for their early detection could substantially reduce the human and economioc cost of these diseases. In this article, the American Cancer Society, the American Diabetes Association, and the American Heart Association review strategies for the prevention and early detection of cancer, cardiovascular disease, and diabetes, as the beginning of a new collaboration among the three organizations. The goal of this joint venture is to stimulate substantial improvements in primary prevention and early detection through collaboration between key organizations, greater public awareness about healthy lifestyles, legislative action that results in more funding for and access to primary prevention programs and research, and reconsideration of the concept of the periodic medical checkup as an effective platform for prevention, early detection, and treatment. CA Cancer J Clin 2004; 54:190-207 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.